Detalhe da pesquisa
1.
Outer membrane vesicle vaccines.
Semin Immunol;
50: 101433, 2020 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33309166
2.
Short Vi-polysaccharide abrogates T-independent immune response and hyporesponsiveness elicited by long Vi-CRM197 conjugate vaccine.
Proc Natl Acad Sci U S A;
117(39): 24443-24449, 2020 09 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32900928
3.
The Background, Role and Approach for Development of a Controlled Human Infection Model for Nontyphoidal Salmonella.
Curr Top Microbiol Immunol;
2021 Dec 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34958419
4.
Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal Salmonella.
Proc Natl Acad Sci U S A;
115(41): 10428-10433, 2018 10 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30262653
5.
Typhoid Conjugate Vaccines and Enteric Fever Control: Where to Next?
Clin Infect Dis;
71(Suppl 2): S185-S190, 2020 07 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32725223
6.
Consensus Report on Shigella Controlled Human Infection Model: Introduction and Overview.
Clin Infect Dis;
69(Suppl 8): S577-S579, 2019 12 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31816066
7.
Consensus Report on Shigella Controlled Human Infection Model: Clinical Endpoints.
Clin Infect Dis;
69(Suppl 8): S591-S595, 2019 12 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31816065
8.
Consensus Report on Shigella Controlled Human Infection Model: Immunological Assays.
Clin Infect Dis;
69(Suppl 8): S596-S601, 2019 12 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31816067
9.
Consensus Report on Shigella Controlled Human Infection Model: Conduct of Studies.
Clin Infect Dis;
69(Suppl 8): S580-S590, 2019 12 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31816068
10.
The Severe Typhoid Fever in Africa Program: Study Design and Methodology to Assess Disease Severity, Host Immunity, and Carriage Associated With Invasive Salmonellosis.
Clin Infect Dis;
69(Suppl 6): S422-S434, 2019 10 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31665779
11.
The essential role of complement in antibody-mediated resistance to Salmonella.
Immunology;
156(1): 69-73, 2019 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30179254
12.
IgG1 Is Required for Optimal Protection after Immunization with the Purified Porin OmpD from Salmonella Typhimurium.
J Immunol;
199(12): 4103-4109, 2017 12 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29127147
13.
Critical Needs in Advancing Shigella Vaccines for Global Health.
J Infect Dis;
225(9): 1500-1503, 2022 05 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34558631
14.
Role of sapA and yfgA in Susceptibility to Antibody-Mediated Complement-Dependent Killing and Virulence of Salmonella enterica Serovar Typhimurium.
Infect Immun;
85(9)2017 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28674031
15.
An O antigen capsule modulates bacterial pathogenesis in Shigella sonnei.
PLoS Pathog;
11(3): e1004749, 2015 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25794007
16.
Vaccines for low-income countries.
Semin Immunol;
25(2): 114-23, 2013 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23757292
17.
Vaccines against poverty.
Proc Natl Acad Sci U S A;
111(34): 12307-12, 2014 Aug 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25136089
18.
The Relationship Between Invasive Nontyphoidal Salmonella Disease, Other Bacterial Bloodstream Infections, and Malaria in Sub-Saharan Africa.
Clin Infect Dis;
62 Suppl 1: S23-31, 2016 Mar 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26933016
19.
Genetic variants associated with non-typhoidal Salmonella bacteraemia in African children.
Lancet;
385 Suppl 1: S13, 2015 Feb 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26312835
20.
Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X.
Proc Natl Acad Sci U S A;
110(47): 19077-82, 2013 Nov 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24191022